Phase 1 Atherosclerosis Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
Metabolic and Metagenomic Effects of Intestinal Microbiome Repopulation in Unexplained Atherosclerosis
Atherosclerosis
Western University, Canada100 enrolled1 locationNCT04410003
Completed
Phase 1
A study to investigate the safety of multiple doses of BRN-002 administered intravenously (IV) in adult (18 to 65 years) healthy male and female participants
Atherosclerosis
Beren Therapeutics, PBC32 enrolled1 locationACTRN12622000198729
Completed
Phase 1
An Open label, Single Ascending Dose Study of Intravenous and Oral Doses of BRN-002 to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Healthy Participants
Atherosclerosis
Beren Therapeutics, PBC30 enrolled1 locationACTRN12621001479897